Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2005-06-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TINQUEUX (51430), Marne
SELAS PHARMACIE DE LA HAUBETTE : revenue, balance sheet and financial ratios
SELAS PHARMACIE DE LA HAUBETTE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TINQUEUX (51430),
this company of category PME
shows in 2022 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DE LA HAUBETTE (SIREN 482643566)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 187 786 €
1 615 504 €
1 441 660 €
N/C
N/C
N/C
933 782 €
Net income
55 562 €
-60 368 €
106 470 €
15 888 €
51 937 €
-4 742 €
31 073 €
32 820 €
40 406 €
EBITDA
N/C
N/C
184 839 €
28 893 €
79 931 €
N/C
N/C
N/C
50 842 €
Net margin
N/C
N/C
4.9%
1.0%
3.6%
N/C
N/C
N/C
4.3%
Revenue and income statement
In 2024, SELAS PHARMACIE DE LA HAUBETTE generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 40 k€ -> 56 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
55 562 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 173%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
172.57%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.098%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DE LA HAUBETTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
341.329
294.943
269.836
307.792
218.955
195.098
125.21
151.627
172.57
Financial autonomy
20.638
22.351
23.919
21.549
25.708
26.898
33.552
31.158
29.098
Repayment capacity
23.164
None
None
None
11.162
25.118
4.745
None
None
Cash flow / Revenue
3.634%
None%
None%
None%
4.618%
1.718%
5.566%
None%
None%
Sector positioning
Debt ratio
172.572024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+13 pts over 3 years
In 2024, the debt ratio of SELAS PHARMACIE DE LA HAU... (172.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
29.1%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-7 pts over 3 years
In 2024, the financial autonomy of SELAS PHARMACIE DE LA HAU... (29.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.75 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELAS PHARMACIE DE LA HAU... (4.75) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 147.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
147.36
Liquidity indicators evolution SELAS PHARMACIE DE LA HAUBETTE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
115.066
93.482
95.815
101.212
90.627
87.016
91.324
85.305
147.36
Interest coverage
25.31
None
None
None
12.339
8.836
1.066
None
None
Sector positioning
Liquidity ratio
147.362024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+17 pts over 3 years
In 2024, the liquidity ratio of SELAS PHARMACIE DE LA HAU... (147.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
1.07x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of SELAS PHARMACIE DE LA HAU... (1.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE DE LA HAUBETTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
97 776 €
0 €
0 €
0 €
182 067 €
193 440 €
118 884 €
0 €
0 €
Inventory turnover (days)
34
0
0
0
42
37
26
0
0
Customer payment term (days)
5
0
0
0
7
9
7
0
0
Supplier payment term (days)
42
0
0
0
60
61
46
0
0
Positioning of SELAS PHARMACIE DE LA HAUBETTE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE DE LA HAUBETTE is estimated at
775 686 €
(range 540 175€ - 1 160 471€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
540k€775k€1160k€
775 686 €Range: 540 175€ - 1 160 471€
NAF 5 année 2024
Valuation method used
Net Income Multiple
55 562 €
×
14.0x
=775 687 €
Range: 540 176€ - 1 160 472€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DE LA HAUBETTE with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DE LA HAUBETTE
What is the revenue of SELAS PHARMACIE DE LA HAUBETTE ?
The revenue of SELAS PHARMACIE DE LA HAUBETTE in 2022 is 2.2 M€.
Is SELAS PHARMACIE DE LA HAUBETTE profitable?
Yes, SELAS PHARMACIE DE LA HAUBETTE generated a net profit of 56 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE DE LA HAUBETTE ?
The headquarters of SELAS PHARMACIE DE LA HAUBETTE is located in TINQUEUX (51430), in the department Marne.
Where to find the tax return of SELAS PHARMACIE DE LA HAUBETTE ?
The tax return of SELAS PHARMACIE DE LA HAUBETTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DE LA HAUBETTE operate?
SELAS PHARMACIE DE LA HAUBETTE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart